We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PIPR:NYSEPiper Sandler Companies Analysis

Data as of 2026-07-23 - not real-time

$76.26

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Piper Sandler delivers robust top‑line growth with revenue expanding at an impressive pace. The firm’s gross margin remains near ninety percent, underscoring a highly profitable business model. Operating and profit margins are comfortably above industry averages, supporting strong earnings generation. Return on equity exceeds twenty percent, indicating efficient capital use. The dividend payout sits well below twenty percent of earnings, providing ample room for dividend sustainability. A discounted cash‑flow model suggests a fair value far above the current market price, implying notable upside.
Technically, the stock trades below its long‑term moving averages, confirming a bearish bias. The fourteen‑day RSI hovers around the midpoint, reflecting a neutral momentum stance. MACD shows a bullish histogram despite a negative line, hinting at a possible short‑term reversal. Volume trends are weakening, and price volatility remains elevated, adding to short‑term uncertainty. Support sits near the low forties level, while resistance caps just below the recent high fifties range. The upcoming Q2 earnings release on July thirtieth could act as a catalyst, especially given the recent pullback after a strong five‑year performance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bearish position relative to long‑term moving averages
  • decreasing volume and elevated volatility
  • upcoming earnings release as a potential catalyst

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant upside implied by discounted cash‑flow valuation
  • strong revenue growth and high profitability margins
  • low dividend payout ratio supporting sustainable income

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • consistent high return on equity and return on assets
  • robust capital position with ample cash relative to debt
  • industry positioning in capital markets with growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin13.97%
P/E Ratio19.3
ROE22.17%
ROA16.48%
Debt/Equity7.33
P/B Ratio3.9
Op. Cash Flow$502.1M
Industry P/E17.7

Technical Analysis

TrendBearish
RSI50.5
Support$70.27
Resistance$81.13
MA 20$74.69
MA 50$77.37
MA 200$81.92
MACDBullish
VolumeDecreasing
Fear & Greed Index89.77

Valuation

Fair Value$193.90
Target Price$88.13
Upside/Downside15.56%
GradeUndervalued
TypeGrowth
Dividend Yield0.94%

Risk Assessment

Beta1.40
Volatility38.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.